Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C24H18BrClN4O3S |
| Molecular Weight | 557.847 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=CC=C(NC(=O)CSC2=NN=C(Br)N2C3=CC=C(C4CC4)C5=C3C=CC=C5)C(Cl)=C1
InChI
InChIKey=MPNGLQDRSJNLPL-UHFFFAOYSA-N
InChI=1S/C24H18BrClN4O3S/c25-23-28-29-24(34-12-21(31)27-19-9-7-14(22(32)33)11-18(19)26)30(23)20-10-8-15(13-5-6-13)16-3-1-2-4-17(16)20/h1-4,7-11,13H,5-6,12H2,(H,27,31)(H,32,33)
| Molecular Formula | C24H18BrClN4O3S |
| Molecular Weight | 557.847 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:10:31 GMT 2025
by
admin
on
Mon Mar 31 19:10:31 GMT 2025
|
| Record UNII |
363Z97G83I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Discovery and development of non-nucleoside reverse-transcriptase inhibitors
Created by
admin on Mon Mar 31 19:10:31 GMT 2025 , Edited by admin on Mon Mar 31 19:10:31 GMT 2025
|
PRIMARY | |||
|
878670-61-2
Created by
admin on Mon Mar 31 19:10:31 GMT 2025 , Edited by admin on Mon Mar 31 19:10:31 GMT 2025
|
PRIMARY | |||
|
363Z97G83I
Created by
admin on Mon Mar 31 19:10:31 GMT 2025 , Edited by admin on Mon Mar 31 19:10:31 GMT 2025
|
PRIMARY | |||
|
16221816
Created by
admin on Mon Mar 31 19:10:31 GMT 2025 , Edited by admin on Mon Mar 31 19:10:31 GMT 2025
|
PRIMARY | |||
|
File:RDEA806.svg
Created by
admin on Mon Mar 31 19:10:31 GMT 2025 , Edited by admin on Mon Mar 31 19:10:31 GMT 2025
|
PRIMARY | Chemical structure of RDEA806, a triazole NNRTI. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET ORGANISM->INHIBITOR |
Non-nucleoside inhibitor
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Originator: Valeant Pharmaceuticals International; Developer: Ardea Biosciences; Class: Antigout, Antiretroviral, Benzoic acid, Small molecule, Triazole; Mechanism of Action: Non-nucleoside reverse transcriptase inhibitor; Highest Development Phase: Discontinued for HIV infections; Most Recent Events: 30 May 2014 Discontinued - Phase-II for HIV infections in Europe, including Germany and the UK prior to May 2014 (PO), 20 Jun 2012 Ardea Biosciences has been acquired by AstraZeneca, 03 Feb 2011 RDEA 806 is still available for licensing as of 03 Feb 2011. http://www.ardeabio.com/
|